Nivalis Therapeutics Inc
- Stock Issuer and Owners
| Nivalis Therapeutics Inc |
| Ticker | ALPN |
| CIK # | 0001626199 |
| CUSIP | 02083G100 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 3122 Sterling Circle, Suite 200, Boulder, CO 80301 |
| Source |
[EDGAR]
|
| Form 3/4/5 Filer |
2011 - 2025 |
|
Alpine Immune Sciences Inc
|
|
|
Durand Remy
|
|
|
Thompson Peter A.
|
|
|
Gold Mitchell
|
|
|
Hernday Natasha
|
|
|
Rickey James Paul
|
|
|
PENG Stanford L
|
|
|
Topper James N
|
|
|
Drappa Jorn
|
|
|
Sandler Andrew Seth
|
|
|
Peetz Christopher
|
|
|
Conway Robert E
|
|
|
Cui Xiangmin
|
|
|
Decheng Capital China Life Sciences USD Fund III, L.P.
|
|
|
Decheng Capital Management III (Cayman), LLC
|
|
|
Venkatesan Jay
|
|
|
FHM Life Sciences VIII LLC
|
|
|
FHM Life Sciences VIII LP
|
|
|
Frazier Life Sciences VIII, L.P.
|
|
|
Heron Patrick J
|
|
|
Alpine ImmunoSciences, L.P.
|
|
|
Alpine Bioventures, GP, LLC
|
|
|
OrbiMed Genesis GP LLC
|
|
|
OrbiMed Advisors LLC
|
|
|
OrbiMed Capital GP VI LLC
|
|
|
Goldberg Zelanna
|
|
|
Sekhri Paul J
|
|
|
Tiger Management LLC
|
|
|
Litton Mark James
|
|
|
Isaly Samuel D
|
|
|
Lampert Mark N
|
|
|
Biotechnology Value Fund II LP
|
|
|
BVF Partners OS Ltd.
|
|
|
BVF Inc/IL
|
|
|
BVF Partners L P/IL
|
|
|
Biotechnology Value Trading Fund OS LP
|
|
|
Biotechnology Value Fund L P
|
|
|
Troha Janice
|
|
|
Carruthers R Michael
|
|
|
Smith Cynthia
|
|
|
Rodman David Malcom
|
|
|
Congleton Jon
|
|
|
Furst Howard P.
|
|
|
Loh Evan
|
|
|
Moore John R
|
|
|
Deerfield Management Company LP Series C
|
|
|
Flynn James E
|
|
|
Gabriel Sherif
|
|
|
Leff Jonathan S
|
|
|
Shoemaker Steven
|
|
|
Deerfield Private Design International, L.P.
|
|
|
Deerfield Private Design Fund II, L.P.
|
|
|
Deerfield Mgmt L.P.
|
|
|
Deerfield Private Design Fund L P
|
|
|
Deerfield Special Situations Fund, L.P.
|
|
|
Deerfield Private Design International II, L.P.
|
|
|
Rock Springs Capital Management LP
|
|
|
Hadley Harbor Master Investors (Cayman) L.P.
|
|
|
Hawkes Bay Master Investors (Cayman) L.P.
|
|
|
Jennison Global Healthcare Master Fund, Ltd.
|
|
|
Estate of Arnold H. Snider, III
|
|
|
Tiger Partners GP, LLC
|
|
|
Tiger Partners LP
|
|
|
Deerfield Private Design International II, Ltd.
|
|
| Form 13F Holdings |
| Firm |
Period |
DFND |
Voting |
Shares |
| RA Capital Management LP |
[2023-03-31]
|
SOLE |
0.0 |
4,688,115.0 |
| OrbiMed Advisors LLC |
[2023-03-31]
|
SOLE |
4,081,592.0 |
4,081,592.0 |
| Great Point Partners LLC |
[2023-03-31]
|
DFND |
0.0 |
3,740,761.0 |
| Lynx1 Capital Management LP |
[2023-03-31]
|
OTR |
0.0 |
3,136,173.0 |
| Frazier Life Sciences Management LP |
[2023-03-31]
|
SOLE |
2,985,757.0 |
2,985,757.0 |
| Paradigm Biocapital Advisors LP |
[2023-03-31]
|
SOLE |
2,317,634.0 |
2,317,634.0 |
| Omega Fund Management LLC |
[2023-03-31]
|
SOLE |
2,029,580.0 |
2,029,580.0 |
| BlackRock Inc. |
[2023-03-31]
|
SOLE |
1,538,456.0 |
1,552,920.0 |
| Vanguard Group Inc |
[2023-03-31]
|
SOLE |
0.0 |
1,334,922.0 |
| Commodore Capital LP |
[2023-03-31]
|
SOLE |
1,325,000.0 |
1,325,000.0 |
| Octagon Capital Advisors LP |
[2023-03-31]
|
SOLE |
1,202,000.0 |
1,202,000.0 |
| Artal Group S.A. |
[2023-03-31]
|
DFND |
1,193,030.0 |
1,193,030.0 |
| Avidity Partners Management LP |
[2023-03-31]
|
SOLE |
989,500.0 |
989,500.0 |
| BVF Inc/IL |
[2023-03-31]
|
DFND |
0.0 |
858,339.0 |
| Geode Capital Management LLC |
[2023-03-31]
|
DFND |
556,207.0 |
556,207.0 |
| State Street Corp |
[2023-03-31]
|
DFND |
321,799.0 |
346,671.0 |
| Renaissance Technologies LLC |
[2023-03-31]
|
SOLE |
330,294.0 |
330,294.0 |
| TCG Crossover Management LLC |
[2023-03-31]
|
SOLE |
253,069.0 |
253,069.0 |
| Affinity Asset Advisors LLC |
[2023-03-31]
|
SOLE |
247,891.0 |
247,891.0 |
| Ghost Tree Capital LLC |
[2023-03-31]
|
SOLE |
200,000.0 |
200,000.0 |
| Sphera Funds Management Ltd |
[2023-03-31]
|
DFND |
200,000.0 |
200,000.0 |
| Northern Trust Corp |
[2023-03-31]
|
DFND |
2,522.0 |
193,987.0 |
| Dimensional Fund Advisors LP |
[2023-03-31]
|
SOLE |
113,157.0 |
126,718.0 |
| HighVista Strategies LLC |
[2023-03-31]
|
SOLE |
90,287.0 |
90,287.0 |
| Bank of New York Mellon Corp |
[2023-03-31]
|
DFND |
65,083.0 |
71,806.0 |
| Charles Schwab Investment Management Inc |
[2023-03-31]
|
SOLE |
67,266.0 |
67,266.0 |
| Connor Clark & Lunn Investment Management Ltd |
[2023-03-31]
|
SOLE |
54,237.0 |
54,237.0 |
| JPMorgan Chase & Co |
[2023-03-31]
|
DFND |
30,026.0 |
48,149.0 |
| Two Sigma Advisers LP |
[2023-03-31]
|
SOLE |
33,575.0 |
40,975.0 |
| Vanguard Group Inc |
[2023-03-31]
|
DFND |
0.0 |
34,787.0 |
Prev | Page 47 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 179171193, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
264520247